search
Back to results

Effect of Early Pain Management at Triage on Opioid Consumption

Primary Purpose

Acute Pain

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Paracetamol
Tramadol/Paracetamol combination
Placebo Oral Tablet
Sponsored by
University of Monastir
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute Pain focused on measuring acute pain, emergency department, opioid consumption

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • over 18 years of age
  • a visual analog scale (VAS) equal to or higher than 30/100 ,
  • having given consent to participation
  • No contraindications to products used in the course of the study.

Exclusion Criteria:

  • having a vital distress that does not allow an adequate assessment of the intensity of the pain
  • an inability to assess pain intensity according to the VAS,
  • swallowing disorders or inability , or a contraindication or an allergy to the treatments used.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Placebo Comparator

    Active Comparator

    Active Comparator

    Arm Label

    group Placebo

    group Paracetamol

    group Tramadol/Paracetamol combination

    Arm Description

    Patients in this group (Placebo Oral Tablet) received two placebo tablets

    Patients in this group received two 500 mg paracetamol tablets

    Patients in this group (Tramadol/Paracetamol combination ) received 2 tablets of Tramadol/Paracetamol combination (37.5mg/325mg)

    Outcomes

    Primary Outcome Measures

    use of rescue opioids
    decreased consumption of intravenous morphine

    Secondary Outcome Measures

    patient satisfaction
    patient satisfaction regarding the overall management in the emergency department measured by likert scale
    Length of emergency department stay
    Pain intensity at emergency department discharge
    Percentage of patients with visual analog scale <30

    Full Information

    First Posted
    July 15, 2017
    Last Updated
    November 28, 2017
    Sponsor
    University of Monastir
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03243006
    Brief Title
    Effect of Early Pain Management at Triage on Opioid Consumption
    Official Title
    Effect of Early Analgesic Treatment on Opioid Consumption
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2017
    Overall Recruitment Status
    Completed
    Study Start Date
    January 1, 2016 (Actual)
    Primary Completion Date
    September 30, 2016 (Actual)
    Study Completion Date
    September 30, 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Monastir

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    introduction: Pain remains one of the most common reasons of emergency department admission. Opioids are overprescribed in emergency departments to treat severe pain. objective: assessing the impact of ealy pain pain management on the use of intravenous morphine and on patient satisfaction.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Acute Pain
    Keywords
    acute pain, emergency department, opioid consumption

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    1500 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    group Placebo
    Arm Type
    Placebo Comparator
    Arm Description
    Patients in this group (Placebo Oral Tablet) received two placebo tablets
    Arm Title
    group Paracetamol
    Arm Type
    Active Comparator
    Arm Description
    Patients in this group received two 500 mg paracetamol tablets
    Arm Title
    group Tramadol/Paracetamol combination
    Arm Type
    Active Comparator
    Arm Description
    Patients in this group (Tramadol/Paracetamol combination ) received 2 tablets of Tramadol/Paracetamol combination (37.5mg/325mg)
    Intervention Type
    Drug
    Intervention Name(s)
    Paracetamol
    Intervention Description
    2 tablets of 500mg of paracetamol
    Intervention Type
    Drug
    Intervention Name(s)
    Tramadol/Paracetamol combination
    Intervention Description
    2 tablets of tramadol/paracetamol combination (32.5mg/325mg)
    Intervention Type
    Drug
    Intervention Name(s)
    Placebo Oral Tablet
    Intervention Description
    2 tablets of placebo
    Primary Outcome Measure Information:
    Title
    use of rescue opioids
    Description
    decreased consumption of intravenous morphine
    Time Frame
    DURING emergency department stay
    Secondary Outcome Measure Information:
    Title
    patient satisfaction
    Description
    patient satisfaction regarding the overall management in the emergency department measured by likert scale
    Time Frame
    When quitting emergency department
    Title
    Length of emergency department stay
    Time Frame
    Until emergency department discharge
    Title
    Pain intensity at emergency department discharge
    Description
    Percentage of patients with visual analog scale <30
    Time Frame
    At emergency department discharge

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: over 18 years of age a visual analog scale (VAS) equal to or higher than 30/100 , having given consent to participation No contraindications to products used in the course of the study. Exclusion Criteria: having a vital distress that does not allow an adequate assessment of the intensity of the pain an inability to assess pain intensity according to the VAS, swallowing disorders or inability , or a contraindication or an allergy to the treatments used.

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Effect of Early Pain Management at Triage on Opioid Consumption

    We'll reach out to this number within 24 hrs